Abstract
I t seems that all players in the healthcare arena need outcomes data - so why not work together? Glaxo Wellcome and QualMed Health Plan * have done just that, joining forces to assess the outcomes of sumatriptan use among health plan members. At the 1996 Congress on Health Outcomes & Accountability [ Washington DC, US; December 1995 ], delegates heard how the two parties formed a successful partnership to gain the outcomes data they each required.
This is a preview of subscription content, log in via an institution to check access.
Additional information
* an IPA network health maintenance organisation (HMO) covering around 60 000 lives
Rights and permissions
About this article
Cite this article
Langsdale, T. Sumatriptan for migraine. Pharmacoecon. Outcomes News 50, 3–4 (1996). https://doi.org/10.1007/BF03269813
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269813